← Leaderboards
Hope S Rugo
University Of California San Francisco
$525,101
Attributed
$1,043,559
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,043,559 · 3
By mechanism
R44$1,036,917 · 1
M01$6,642 · 2
Top collaborators
- Kate Dilligan1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Leslie Z Benet$3,583,449
- Laura N Bull$7,328,977
- Warner C Greene$31,742,202
- Judith T. Moskowitz$25,368,406
- Lily Y Jan$24,385,637
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBreast NeoplasmsHuman SubjectMetastasisClinicCancer TherapyBloodChemotherapeutic AgentBreast Cancer TherapyChemotherapyDry IceChargeColorCombination ChemotherapyCommon Terminology Criteria For Adverse EventsCommercializationComparative EfficacyCostCytochrome P450DesignDevicesDrug InteractionsCaringBody Image
Grant awards (4)
Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia$1,036,917
R44 · FY2023 · CA
AG-013736 WITH DOCETAXEL VS DOCETAXEL ALONE IN METASTATIC BREAST CANCER$4,209
M01 · FY2005 · RR
AG-013736 With Docetaxel Vs Docetaxel Alone in Metastatic Breast Cancer$2,129
M01 · FY2004 · RR
Herba Scutellaria Barbatae (HSB) for Metastatic Breast Cancer$304
M01 · FY2004 · RR